Navi Daniel, Koo John
University of California, Davis School of Medicine, Davis, CA, USA.
J Drugs Dermatol. 2006 Feb;5(2):109-15.
It is the experience of dermatologists worldwide that a significant proportion of their patient population has underlying psychological components to their dermatologic complaints. Since these patients are often reluctant to see a mental health professional, the effective management of the underlying psychopathology may require the use of psychotropic medications by the dermatologists. This paper aims to update dermatologists on recent safety information on some of the most commonly prescribed psychotropic medications in psychodermatology. In the process it will also address the implications of these recent safety updates for prescribing clinicians.
全球皮肤科医生的经验表明,他们的很大一部分患者群体的皮肤问题存在潜在的心理因素。由于这些患者往往不愿去看心理健康专业人员,对潜在精神病理学的有效管理可能需要皮肤科医生使用精神药物。本文旨在向皮肤科医生介绍心理皮肤病学中一些最常用精神药物的最新安全信息。在此过程中,还将探讨这些最新安全更新对开处方的临床医生的影响。